Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA

Latest

George Vincent named Kroger secretary and general counsel
Vincent has counseled national and international businesses on strategic growth and is a well-regarded leader in the legal community.


PLMA reports that store brand sales outpaced national brands in first half of 2025
PLMA projects that total store brand sales will approach $277 billion in 2025, up from a record $271 billion in 2024.

Natural Choice Foods wins FMI’s 2025 Food Safety Innovation Award
“Natural Choice Foods is transforming how the industry views food waste,” said Ashley Eisenbeiser, Vice President of Food and Product Safety Programs at FMI.